COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | +100.0% | 199 | +3.6% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 192 | +86.4% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 103 | +37.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 75 | +1400.0% | 0.00% | – |
| Q1 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 5 | -99.9% | 0.00% | -100.0% |
| Q2 2020 | $77,000 | -32.5% | 4,253 | -38.9% | 0.01% | -44.4% |
| Q1 2020 | $114,000 | +185.0% | 6,965 | +207.0% | 0.01% | +350.0% |
| Q4 2019 | $40,000 | +300.0% | 2,269 | +378.7% | 0.00% | +100.0% |
| Q3 2019 | $10,000 | -97.3% | 474 | -97.2% | 0.00% | -96.2% |
| Q2 2019 | $369,000 | +36800.0% | 16,732 | +16801.0% | 0.03% | – |
| Q4 2017 | $1,000 | -80.0% | 99 | -55.8% | 0.00% | – |
| Q1 2017 | $5,000 | +400.0% | 224 | +322.6% | 0.00% | – |
| Q4 2016 | $1,000 | -92.9% | 53 | -89.8% | 0.00% | -100.0% |
| Q3 2016 | $14,000 | – | 519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |